Key facts
- This page summarizes Vlad Vitoc's Form 4 filing for MAIA Biotechnology, Inc. (MAIA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jun 2026, 09:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.3634 to $1.4150, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Footnote F2
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.